Duramune Adult is the first USDA-licensed vaccine with 3 year virus challenge data against a trio of deadly canine diseases: canine distemper (CDV), canine adenovirus (CAV-2), and canine parvovirus (CPV). The vaccine is particularly well suited as a booster for adult dogs if an extended vaccination interval program is being utilized. This treatment applied to Dogs only.
Canine distemper (CDV) is a highly contagious viral disease most common in unvaccinated puppies, but it can affect any dog with a poor immune status. It attacks many organs in addition to the nervous system.
Transmission: The virus is spread through coughing, sneezing, and other body secretions.
Clinical Signs: Fever, loss of appetite, diarrhea, listlessness, vomiting, slobbering, and discharge from the eyes and nose. In more advanced stages, the disease may cause convulsions, paralysis, and death.
Canine Adenovirus Type 2 is a highly infectious respiratory disease in dogs. It causes local infections in the upper respiratory tract and may progress to lower respiratory disease in puppies or debilitated adult or senior dogs.
Transmission: The virus is transmitted via air-borne respiratory secretions.
Clinical Signs: Runny nose, possible fever, and dry harsh coughing followed by retching and gagging.
Canine parvovirus (CPV) is an intestinal disease with rapid onset and varying degrees of illness. It most commonly affects puppies with mild to severe illness. The disease can cause death.
Transmission: Canine parvovirus is transmitted from one dog to another through feces or from objects contaminated by feces. It can be carried on a dog’s hair and feet, as well as on contaminated cages, shoes, and other objects. Because food and water dishes, cages, bedding, litter boxes, rugs, and soil can become contaminated with the virus, the dog’s environment can become a reservoir for infection.
Clinical Signs: Depression, loss of appetite, vomiting, abdominal pain, and severe bloody diarrhea.
Primary Vaccination: A recommended vaccination schedule should start at or about 6 weeks of age. The presence of maternal antibody is known to interfere with the development of active immunity. Puppies should be revaccinated every 2 to 3 weeks until 12 weeks of age. All dogs over 12 weeks of age should initially receive one dose of this product and a second dose 2 to 3 weeks later.
Revaccination: Dogs may be vaccinated annually with one dose. The CPV, CAV2 and CDV fractions of this product have also been studied in a longer revaccination interval program. The results of the 3 year duration of immunity studies are described in the enclosed package insert.
0
0
